Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

The Relationship Between Cortical Inhibition and Electroconvulsive Therapy in the Treatment of Major Depressive Disorder.

Voineskos D, Levinson AJ, Sun Y, Barr MS, Farzan F, Rajji TK, Fitzgerald PB, Blumberger DM, Daskalakis ZJ.

Sci Rep. 2016 Dec 9;6:37461. doi: 10.1038/srep37461.

2.

Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex.

Pirnia T, Joshi SH, Leaver AM, Vasavada M, Njau S, Woods RP, Espinoza R, Narr KL.

Transl Psychiatry. 2016 Jun 7;6(6):e832. doi: 10.1038/tp.2016.102.

3.

Effects of Hesel-coil deep transcranial magnetic stimulation for depression - a systematic review.

Nordenskjöld A, Mårtensson B, Pettersson A, Heintz E, Landén M.

Nord J Psychiatry. 2016 Oct;70(7):492-7. doi: 10.3109/08039488.2016.1166263. Review.

4.

A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression.

Eisendrath SJ, Gillung E, Delucchi KL, Segal ZV, Nelson JC, McInnes LA, Mathalon DH, Feldman MD.

Psychother Psychosom. 2016;85(2):99-110. doi: 10.1159/000442260.

PMID:
26808973
5.

Severity of Depression Predicts Remission Rates Using Transcranial Magnetic Stimulation.

Grammer GG, Kuhle AR, Clark CC, Dretsch MN, Williams KA, Cole JT.

Front Psychiatry. 2015 Sep 1;6:114. doi: 10.3389/fpsyt.2015.00114.

6.

Advances in the Management of Treatment-Resistant Depression.

Holtzheimer PE.

Focus (Am Psychiatr Publ). 2010 Fall;8(4):488-500.

7.

Sprouty2 in the dorsal hippocampus regulates neurogenesis and stress responsiveness in rats.

Dow AL, Lin TV, Chartoff EH, Potter D, McPhie DL, Van't Veer AV, Knoll AT, Lee KN, Neve RL, Patel TB, Ongur D, Cohen BM, Carlezon WA Jr.

PLoS One. 2015 Mar 30;10(3):e0120693. doi: 10.1371/journal.pone.0120693.

8.

Modulation of interhemispheric functional coordination in electroconvulsive therapy for depression.

Wei Q, Tian Y, Yu Y, Zhang F, Hu X, Dong Y, Chen Y, Hu P, Hu X, Wang K.

Transl Psychiatry. 2014 Sep 30;4:e453. doi: 10.1038/tp.2014.101.

9.

Leukocyte Gene Expression in Patients with Medication Refractory Depression before and after Treatment with ECT or Isoflurane Anesthesia: A Pilot Study.

Iacob E, Tadler SC, Light KC, Weeks HR, Smith KW, White AT, Hughen RW, VanHaitsma TA, Bushnell LA, Light AR.

Depress Res Treat. 2014;2014:582380. doi: 10.1155/2014/582380.

10.

Current electroconvulsive therapy practice and research in the geriatric population.

Kerner N, Prudic J.

Neuropsychiatry (London). 2014 Feb;4(1):33-54.

11.

Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression.

Weeks HR 3rd, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, Landvatter JD, Chelune GJ, Suchy Y, Clark E, Cahalan MK, Bushnell L, Sakata D, Light AR, Light KC.

PLoS One. 2013 Jul 26;8(7):e69809. doi: 10.1371/journal.pone.0069809.

12.

Relapse following successful electroconvulsive therapy for major depression: a meta-analysis.

Jelovac A, Kolshus E, McLoughlin DM.

Neuropsychopharmacology. 2013 Nov;38(12):2467-74. doi: 10.1038/npp.2013.149.

13.

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review.

Tokutsu Y, Umene-Nakano W, Shinkai T, Yoshimura R, Okamoto T, Katsuki A, Hori H, Ikenouchi-Sugita A, Hayashi K, Atake K, Nakamura J.

Clin Psychopharmacol Neurosci. 2013 Apr;11(1):34-8. doi: 10.9758/cpn.2013.11.1.34.

14.

Association of cerebral metabolic activity changes with vagus nerve stimulation antidepressant response in treatment-resistant depression.

Conway CR, Chibnall JT, Gebara MA, Price JL, Snyder AZ, Mintun MA, Craig AD, Cornell ME, Perantie DC, Giuffra LA, Bucholz RD, Sheline YI.

Brain Stimul. 2013 Sep;6(5):788-97. doi: 10.1016/j.brs.2012.11.006.

15.

Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.

Prudic J, Haskett RF, McCall WV, Isenberg K, Cooper T, Rosenquist PB, Mulsant BH, Sackeim HA.

J ECT. 2013 Mar;29(1):3-12. doi: 10.1097/YCT.0b013e31826ea8c4.

16.

Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study.

Nordenskjöld A, von Knorring L, Engström I.

BMC Psychiatry. 2012 Aug 17;12:115. doi: 10.1186/1471-244X-12-115.

17.

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R.

Mol Psychiatry. 2013 Jan;18(1):93-100. doi: 10.1038/mp.2012.93.

18.

Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.

Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE 3rd, George MS, Sackeim HA, Lisanby SH.

Depress Anxiety. 2012 Oct;29(10):883-90. doi: 10.1002/da.21967.

19.

Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Conway CR, Chibnall JT, Gangwani S, Mintun MA, Price JL, Hershey T, Giuffra LA, Bucholz RD, Christensen JJ, Sheline YI.

J Affect Disord. 2012 Aug;139(3):283-90. doi: 10.1016/j.jad.2012.02.007.

20.

Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.

Conway CR, Sheline YI, Chibnall JT, Bucholz RD, Price JL, Gangwani S, Mintun MA.

Brain Stimul. 2012 Apr;5(2):163-71. doi: 10.1016/j.brs.2011.03.001.

Items per page

Supplemental Content

Support Center